News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lianbio ADR
(NQ:
LIAN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lianbio ADR
< Previous
1
2
3
4
Next >
What's Going On With LianBio (LIAN) Stock?
March 15, 2024
LianBio shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its ADSs from the Nasdaq Global Market.
Via
Benzinga
Why Is LianBio (LIAN) Stock Moving Today?
March 15, 2024
LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
LianBio Announces Voluntarily Delisting from Nasdaq
February 28, 2024
From
LianBio
Via
GlobeNewswire
B of A Securities Downgrades LianBio: Here's What You Need To Know
January 03, 2024
Via
Benzinga
Why LianBio Stock Is Skyrocketing Today
October 24, 2023
Investors are loving LianBio's new deal with Bristol Myers Squibb.
Via
The Motley Fool
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
February 17, 2024
LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its...
Via
Talk Markets
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Via
Benzinga
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
February 13, 2024
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
LianBio Announces Completion of Strategic Review
February 13, 2024
LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividend
From
LianBio
Via
GlobeNewswire
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
December 31, 2023
Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program....
Via
Talk Markets
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
December 26, 2023
From
LianBio
Via
GlobeNewswire
LianBio Announces Departure of Chief Financial Officer
December 20, 2023
From
LianBio
Via
GlobeNewswire
LianBio Announces Departure of Chief Executive Officer
December 19, 2023
From
LianBio
Via
GlobeNewswire
LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences
December 06, 2023
From
LianBio
Via
GlobeNewswire
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
December 02, 2023
LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of...
Via
Talk Markets
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
December 01, 2023
From
LianBio
Via
GlobeNewswire
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
LianBio
Via
GlobeNewswire
LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
October 30, 2023
From
LianBio
Via
GlobeNewswire
ArcelorMittal, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 30, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its...
Via
Talk Markets
Why LianBio Stock Is Shooting Through the Roof This Week
October 27, 2023
LianBio stock is seeing explosive gains, and it's one of this week's biggest winners.
Via
The Motley Fool
LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023
October 25, 2023
From
LianBio
Via
GlobeNewswire
Raymond James Maintains Outperform Rating for LianBio: Here's What You Need To Know
October 25, 2023
Via
Benzinga
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations
October 24, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 24, 2023
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.
Via
Benzinga
Why Is LianBio (LIAN) Stock Up 130% Today?
October 24, 2023
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 24, 2023
Via
Benzinga
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings
October 24, 2023
U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why LianBio Stock Is Ripping Higher Today
October 24, 2023
LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.